Zhu, Binruo
Wang, Jie
Chen, Kang
Yan, Wenhua
Wang, Anping
Wang, Weiqing
Gao, Zhengnan
Tang, Xulei
Yan, Li
Wan, Qin
Luo, Zuojie
Qin, Guijun
Chen, Lulu
Mu, Yiming http://orcid.org/0000-0002-3344-3540
Funding for this research was provided by:
Chinese Society of Endocrinology, the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044)
the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001)
the National High Technology Research and Development Program of China (863 Program, 2011AA020107)
National Science Foundation of China (81300717)
the REACTION Study
National Science and Technology Major Project 288 (2011ZX09307-001-08)
Article History
Received: 28 March 2020
Accepted: 2 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: The study protocol was approved by the Committee on Human Research at RuiāJin Hospital affiliated with the School of Medicine, Shanghai Jiao Tong University. Written informed consents were obtained from all participants before data collection.
: Not applicable.
: The authors declare that they have no competing interests.